Stock News | Market Tamer Stock and Options Training

Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy

Baxter to Host Annual Meeting of Stockholders in Virtual Format

Don't 'run away' from tech, but do broaden out: Strategist

Yahoo Finance Live revisits the calls made at the end of last year to see which hold up and which are in need of repositioning. Laffer Tengler Investments CEO & CIO Nancy Tengler and Great Hill Capital Chairman and Managing Member Thomas Hayes join Yahoo Finance to revisit and update last year's calls. Hayes outlines his market strategy amid a surging market: "We've been publicly bullish nonstop for a year and a half, and we've recently become more cautious. We're up 17 out of the last 21 weeks. No 2% pullback in the last 100 trading days. So, in recent weeks, we put on a 2% hedge: 1% put spreads on the S&P, 1% put spreads on the semiconductor index, and 98% long. So if we're right, those have an expected value of 5x each." Tengler addresses risks on her radar: "We started broadening out the portfolio, really to have the improvement in some of the names that we've seen in healthcare, financials, some of the more cyclical names...But my biggest concern is that the Fed seems to be, I guess, walking away from their data dependence, and I'll put quotes around that, that they've had in the past. And it seems they're determined to cut. We've drawn an analogy to the 90s. We think you can have higher inflation, but not materially higher. So that's my worry, that we get a surge in inflation because the Fed is too easy." For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino

Should You Hold Baxter International (BAX)?

Baxter to close Massachusetts site, lay off 59 people

Insider Sell: EVP, Chief HR Officer Jeanne Mason Sells 64,488 Shares of Baxter International ...

Baxter considers selling kidney care unit to private equity

Baxter to Present at Raymond James 45th Annual Institutional Investors Conference

It Might Not Be A Great Idea To Buy Baxter International Inc. (NYSE:BAX) For Its Next Dividend

20 Fastest Growing Biotech Companies in the US